EU Weighs New Trade Defenses as China Trade War Threatens Key Sectors Nvidia Earnings in Focus Geopolitical Commentary on China Chips Could Move Markets Barnes Noble CEO James Daunt Clarifies Stance on AIGenerated Books A Straightforward Rejection of AI Books Nvidia Earnings Spotlight Jensen Huangs Commentary on China and US Policy in Focus Student Loan Inquiry Receives Over 52000 Responses Highlighting Widespread Financial Distress Among Graduates Everpure Stock Drops After Earnings What Investors Need to Know High Tide Inc Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains RCON Q4 2025 Earnings NarrowerThanExpected Loss Drives Optimism Despite Revenue Void AZTR Q1 2026 Earnings Significant EPS Miss Amidst EarlyStage Development Globant Q1 2026 Earnings Mixed Quarter with Slight EPS Miss and Modest Stock Decline GAP Q1 2026 Earnings EPS Slightly Misses Estimates Amid Challenging Retail Environment Baker Hughes Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience Solaris Energy Infrastructure SEI Advances 148 Key Support and Resistance Levels in Focus Revvity RVTY Holds Near Support as Consolidation Continues YXTCOM Group Holding YXT edges up 159 as stock holds near 045 resistance level LeonaBio Inc LONA Rises 145 as Shares Approach Key Resistance at 103 Click Holdings Limited CLIK Surges Nearly 10 Amid Improved Market Sentiment Siebert Financial Corp SIEB Q4 2025 Earnings Modest Loss Reported Amidst Quiet Quarter QGEN Q1 2026 Earnings EPS Slightly Below Estimates Despite Positive Stock Response California BanCorp BCAL Q1 2026 Earnings EPS Beats Estimates by 276 on Steady Operational Execution The Brand House Collective Inc TBHC Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges Betterware de Mexico BWMX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Shares Edge Higher Jiayin Group Q4 2024 Earnings Strong EPS Performance Amid Market Headwinds Bernstein Highlights CVS Healths Potential for Medicare Advantage Turnaround KURA Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress OFS Capital Corporation OFS Edges Higher Testing Resistance at 360